Show simple item record

dc.contributor.authorAntolin, AA
dc.contributor.authorWorkman, P
dc.contributor.authorAl-Lazikani, B
dc.date.accessioned2020-06-03T08:44:54Z
dc.date.issued2019-11-28
dc.identifier.citationFuture medicinal chemistry, 2019
dc.identifier.issn1756-8919
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3672
dc.identifier.eissn1756-8927
dc.identifier.doi10.4155/fmc-2019-0231
dc.description.abstractHigh-quality small molecule chemical probes are extremely valuable for biological research and target validation. However, frequent use of flawed small-molecule inhibitors produces misleading results and diminishes the robustness of biomedical research. Several public resources are available to facilitate assessment and selection of better chemical probes for specific protein targets. Here, we review chemical probe resources, discuss their current strengths and limitations, and make recommendations for further improvements. Expert review resources provide in-depth analysis but currently cover only a limited portion of the liganded proteome. Computational resources encompass more proteins and are regularly updated, but have limitations in data availability and curation. We show how biomedical scientists may use these resources to choose the best available chemical probes for their research.
dc.formatPrint-Electronic
dc.languageeng
dc.language.isoeng
dc.publisherFuture Science Ltd
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titlePublic resources for chemical probes: the journey so far and the road ahead.
dc.typeJournal Article
dcterms.dateAccepted2019-09-30
rioxxterms.versionofrecord10.4155/fmc-2019-0231
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2019-11-28
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfFuture medicinal chemistry
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Computational Biology and Chemogenomics
pubs.publication-statusPublished
pubs.embargo.termsNot known
icr.researchteamComputational Biology and Chemogenomics
dc.contributor.icrauthorWorkman, Paul
dc.contributor.icrauthorAl-Lazikani, Bissan


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0